Join
Live feed
·
INSIDERFilingvia Quantisnow
Cumberland Pharmaceuticals Inc. logo

Amendment: Director Jones James was granted 2,500 shares, increasing direct ownership by 6% to 41,646 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CPIX· Cumberland Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CPIX (Cumberland Pharmaceuticals Inc.) and more on Quantisnow.